Novel orally active somotostatin analogs for the treatment of acromegaly

Dr Stephen Betz of Crinetics Pharmaceuticals talks with NEN at ICN 2018 Toronto about his research on the development of treatments for acromegaly; a condition where a pituitary adenoma causes growth hormone hypersecretion causing gigantism in children and abnormal growths in adults.

Interview by Dr. Julie Ann Lough


Author: Ellen Grunewald

Leave a Reply